findmyKOL
Clinical trialNCT02542267CompletedInterventional

In-Stent Restenosis Post-Approval Study

SponsorW.L.Gore & AssociatesEnrollment108Peripheral Artery DiseaseVascular Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of the ISR 14-04 study is to evaluate post-market safety and effectiveness of GORE® VIABAHN® Endoprosthesis for treatment of In-Stent Restenosis of the Superficial Femoral Artery.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Klinikum Rosenheim

    Rosenheim, Germany

Italy
  • Azienda Ospedaliera Santa Maria Nuova Di Reggio Emilia

    Reggio Emilia, Italy

Sweden
  • Skånes Universitetssjukhus

    Malmö, Sweden

United States
  • Mount Sinai Medical Center

    Miami, Florida, United States

  • Kaiser Foundation Hospital

    Honolulu, Hawaii, United States

  • Rockford Cardiovascular Associates

    Rockford, Illinois, United States

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa, United States

  • Cardiovascular Institute of the South

    Houma, Louisiana, United States

  • Covenant Medical Center, Inc.

    Saginaw, Michigan, United States

  • Munson Medical Center

    Traverse City, Michigan, United States

  • Midwest Aortic and Vascular Institute (mavi)

    North Kansas City, Missouri, United States

  • New York Presbyterian Hospital/weill Cornell Medical Center

    New York, New York, United States

  • New York University Langone Medical Center

    New York, New York, United States

  • North Carolina Heart and Vascular

    Raleigh, North Carolina, United States

  • Sanford Health

    Fargo, North Dakota, United States

  • Providence Heart Clinic

    Portland, Oregon, United States

  • St. Vincent'S Consultants in Cardiovascular Disease

    Erie, Pennsylvania, United States

  • the Miriam Hospital

    Providence, Rhode Island, United States

  • Greenville Hospital System

    Greenville, South Carolina, United States

  • Texas Health Research - Presbyterian Heart and Vascular

    Dallas, Texas, United States

  • Texas Health Research - Presbyterian Hospital of Plano

    Plano, Texas, United States

  • Swedish Medical Center - Heart and Vascular Research

    Seattle, Washington, United States

  • Charleston Area Medical Center

    Charleston, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2015
Primary completion
31 Jul 2019
Completion
31 Jul 2021
Last update posted
16 Oct 2023
Registered enrollment
108
Registry id
NCT02542267

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.